Navigation Links
Ann E. Berman To Join the Board of Directors of Cantel Medical Corp.
Date:3/22/2011

LITTLE FALLS, N.J., March 22, 2011 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) today announced the appointment of Ann E. Berman to serve as an independent member of Cantel's Board of Directors.

Ms. Berman is the former Chief Financial Officer (2002-2006) of Harvard University. As CFO of Harvard, Ms. Berman was responsible for an operating budget of more than $2.8 billion, and net assets in excess of $30 billion. As CFO, Ms. Berman brought a focus on the quality of financial management and "best practice" standards to Harvard. She was responsible for establishing and maintaining an adequate and effective internal control structure within the University, and worked closely with the University's audit committee to minimize risk. Her areas of responsibility included financial strategy and policy; Treasury functions, including debt issuance and cash management; risk management and audit services; oversight and administration of government sponsored research; financial reporting; financial operations; and budget and financial planning.

In her role on the Harvard Management Company Board, Ms. Berman participated in the work of the Finance/Audit Committee and the Valuation Committee. She was responsible for a governance review of the Management Company and its Board.

Ms. Berman serves on the Board of Directors and Audit Committee of Loews Corporation, a diversified holding company, and as a board member and the Chair of the Audit Committee of Eaton Vance Corporation, an investment manager of over $150 billion in investment funds and separate accounts.

Before moving into higher education administration, Ms. Berman was a partner at Richard A. Eisner & Co., a New York-based regional accounting firm, where she specialized in tax and consulting work for a wide range of corporate and individual clients. She began her career with Price Waterhouse & Co., where she worked in both audit and taxation. Ms. Berman holds a B.A. from Cornell University where she was elected to Phi Beta Kappa, and an MBA from the Wharton School of the University of Pennsylvania. She is also a certified public accountant.

Charles M. Diker, Cantel's Chairman, commented, "We are delighted to have somebody as accomplished as Ann join our board, and we look forward to benefitting from her broad experience and expertise in financial management, reporting, and corporate governance."

About Cantel Medical Corp.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
2. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
3. American Board of Internal Medicine President Named to Alzheimers Study Group
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
6. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
8. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
9. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
10. Silence Therapeutics Announces Board Changes
11. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... 2016 Revolutionary technology includes multi-speaker ... , industry leaders in advanced audiology and hearing aid ... Opn ™, the world,s first internet connected hearing aid ... devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) ... of ,world firsts,: , TwinLink™ - the ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):